The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

R. Iacovelli, M. Cossu Rocca, L. Galli, R. Sabbatini, U. De Giorgi, D. Santini, G. Facchini, A. Mosca, F. Atzori, P. Zucali, G. Fornarini, F. Massari, S. Buti, R. Ricotta, C. Masini, I. Toscani, E. Biasco, A. Guida, C. Lolli, D. De LisiS. Rossetti, C. Terrone, M. Scartozzi, C. Miggiano, A. Pastorino, M. Bersanelli, G. Carlo-Stella, C. Pinto, E. Nobili, F. Nolè, G. Tortora, C. Porta

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences